Search

Your search keyword '"Mullan, Brendan"' showing total 162 results

Search Constraints

Start Over You searched for: Author "Mullan, Brendan" Remove constraint Author: "Mullan, Brendan"
162 results on '"Mullan, Brendan"'

Search Results

1. Star Clusters in Tidal Debris

2. Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma.

3. Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas

4. Population Growth, Energy Use, and the Implications for the Search for Extraterrestrial Intelligence

5. The Astrobiology of the Anthropocene

7. A Tale of Two Tails: Exploring Stellar Populations in the Tidal Tails of NGC 3256

8. The \^G Infrared Search for Extraterrestrial Civilizations with Large Energy Supplies. III. The Reddest Extended Sources in WISE

9. Everolimus improves the efficacy of dasatinib in PDGFR[alpha]-driven glioma

10. Tidal Tails of Minor Mergers II: Comparing Star Formation in the Tidal Tails of NGC 2782

11. Star clusters in tidal debris

13. Smooth and Starburst Tidal Tails in the GEMS and GOODS Fields

17. CSIG-09. THERAPEUTIC TARGETING OF PRENATAL PONTINE ID1 SIGNALING IN DIFFUSE MIDLINE GLIOMA

18. Blood-brain barrier–adapted precision medicine therapy for pediatric brain tumors

19. CSF H3F3A K27M circulating tumor DNA copy number quantifies tumor growth and in vitro treatment response

20. Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma

22. ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitization

23. TAMI-79. THERAPEUTIC REVERSAL OF PRENATAL PONTINE ID1 SIGNALING IN DIPG

24. Employment Retention, Area of Origin and Type of Social Support among Refugees in the Chicago Area.

29. EPCT-07. ID1 IS A KEY TRANSCRIPTIONAL REGULATOR OF DIPG INVASION AND IS TARGETABLE WITH CANNABIDIOL

30. Therapeutic reversal of prenatal pontine ID1 signaling in DIPG

31. Everolimus improves the efficacy of dasatinib in the treatment of PDGFRA-driven glioma

32. EXCESS, SURPLUS LINES, AND REINSURANCE

33. ATRX Loss in Glioma Results in Epigenetic Dysregulation of Cell Cycle Phase Transition

34. DIPG-59. UPREGULATION OF PRENATAL PONTINE ID1 SIGNALING IN DIPG

35. CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC201 IN H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA

36. TAMI-29. MULTIFACTORIAL UPREGULATION OF ID1 DRIVES DIPG INVASIVENESS AND IS THERAPEUTICALLY TARGETABLE

37. CBIO-03. ATRX LOSS IN GLIOMA RESULTS IN EPIGENETIC DYSREGULATION OF CELL CYCLE PHASE TRANSITION

38. Clinical efficacy and predictive biomarkers of ONC201 in H3 K27M-mutant diffuse midline glioma

39. Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma

40. GENE-17. ATRX LOSS IN GLIOMA RESULTS IN EPIGENETIC DYSREGULATION OF THE G2/M CHECKPOINT AND SENSITIVITY TO ATM INHIBITION

41. PDCT-12. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA

42. EXTH-47. THERAPEUTIC REVERSAL OF PRENATAL PONTINE ID1 SIGNALING IN DIPG

43. Searches for Technosignatures: The State of the Profession

44. The effect of everolimus on CNS penetration and efficacy of dasatinib in the treatment of PDGFRA-driven glioma.

45. HGG-08. ATRX LOSS IN PEDIATRIC GBM RESULTS IN EPIGENETIC DYSREGULATION OF G2/M CHECKPOINT MAINTENANCE AND SENSITIVITY TO ATM INHIBITION

46. HGG-03. EVEROLIMUS TREATMENT IMPROVES THE CNS PENETRATION AND EFFICACY OF DASATINIB IN THE TREATMENT OF PDGFRA-DRIVEN PEDIATRIC HIGH-GRADE GLIOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA

47. Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations

48. Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors

49. PDTM-29. CSF H3F3A K27M CIRCULATING TUMOR DNA COPY NUMBER QUANTIFIES TUMOR GROWTH AND TREATMENT RESPONSE

50. Processes of Hispanic and Black Spatial Assimilation.

Catalog

Books, media, physical & digital resources